American Well (NYSE:AMWL – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.
Other equities analysts have also issued reports about the company. Weiss Ratings restated a “sell (e+)” rating on shares of American Well in a research note on Wednesday, October 8th. Wells Fargo & Company cut their price objective on American Well from $12.00 to $9.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. Finally, Stifel Nicolaus lowered their target price on shares of American Well from $8.00 to $6.00 and set a “hold” rating on the stock in a research note on Wednesday, November 5th. One investment analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, American Well has an average rating of “Hold” and a consensus target price of $8.33.
View Our Latest Stock Analysis on AMWL
American Well Trading Up 2.8%
American Well (NYSE:AMWL – Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($1.74) EPS for the quarter, beating the consensus estimate of ($1.83) by $0.09. The firm had revenue of $56.29 million during the quarter, compared to the consensus estimate of $54.56 million. American Well had a negative net margin of 42.80% and a negative return on equity of 39.80%. American Well has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, equities analysts forecast that American Well will post -9.34 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, insider Dmitry Zamansky sold 25,605 shares of American Well stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $6.77, for a total value of $173,345.85. Following the transaction, the insider owned 197,711 shares in the company, valued at approximately $1,338,503.47. The trade was a 11.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Deborah C. Jackson sold 4,531 shares of the stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $6.56, for a total value of $29,723.36. Following the sale, the director owned 39,132 shares of the company’s stock, valued at $256,705.92. This represents a 10.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 49,383 shares of company stock worth $331,514 in the last 90 days. 12.80% of the stock is owned by company insiders.
Institutional Trading of American Well
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. OMERS ADMINISTRATION Corp grew its holdings in shares of American Well by 207.9% in the first quarter. OMERS ADMINISTRATION Corp now owns 32,331 shares of the company’s stock worth $255,000 after purchasing an additional 21,831 shares during the last quarter. Goldman Sachs Group Inc. boosted its position in American Well by 280.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company’s stock valued at $510,000 after buying an additional 47,745 shares during the period. Jane Street Group LLC grew its holdings in American Well by 232.9% in the 1st quarter. Jane Street Group LLC now owns 64,112 shares of the company’s stock worth $505,000 after acquiring an additional 44,852 shares during the last quarter. Acadian Asset Management LLC increased its position in shares of American Well by 19.5% in the first quarter. Acadian Asset Management LLC now owns 188,217 shares of the company’s stock valued at $1,481,000 after acquiring an additional 30,669 shares during the period. Finally, Corton Capital Inc. raised its stake in shares of American Well by 71.7% during the second quarter. Corton Capital Inc. now owns 27,402 shares of the company’s stock valued at $244,000 after acquiring an additional 11,445 shares during the last quarter. Institutional investors own 56.05% of the company’s stock.
American Well Company Profile
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
Featured Articles
- Five stocks we like better than American Well
- Industrial Products Stocks Investing
- 3 Big Earnings Misses: Is It Time to Buy the Dip?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Is Robinhood’s 11% Post-Earnings Fall a Buy-the-Dip Opportunity?
- Following Congress Stock Trades
- AI Demand Is Coming—Is Microchip Technology Ready?
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.
